Adaptive Biotechnologies (ADPT) News Today $9.84 +2.48 (+33.70%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$9.82 -0.02 (-0.15%) As of 05:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Tudor Investment Corp ET AL Sells 57,284 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)Tudor Investment Corp ET AL trimmed its holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 11.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 458,488 shares of the company's stoMay 5 at 4:52 AM | marketbeat.comBarclays PLC Grows Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)Barclays PLC lifted its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 15.6% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 266,066 shares of the company's stock after acquiring an additional 35,889 shares during thMay 5 at 3:27 AM | marketbeat.comAdaptive Biotechnologies Corporation (NASDAQ:ADPT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.57May 4 at 10:25 AM | finance.yahoo.comAdaptive Biotechnologies (NASDAQ:ADPT) Hits New 12-Month High Following Better-Than-Expected EarningsAdaptive Biotechnologies (NASDAQ:ADPT) Reaches New 12-Month High Following Earnings BeatMay 4 at 10:20 AM | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Sets New 12-Month High on Strong EarningsMay 4 at 1:23 AM | americanbankingnews.comAdaptive Biotechnologies First Quarter 2025 Earnings: Beats ExpectationsMay 3 at 7:23 PM | uk.finance.yahoo.comAdaptive Biotechnologies stock soars on Q1 earnings beatMay 2 at 11:42 PM | investing.comPDT Partners LLC Increases Stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT)PDT Partners LLC boosted its position in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 12.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 316,281 shares of the company's stock after acquiring an additional 35,899 shares during the perMay 2 at 6:32 AM | marketbeat.comAdaptive Biotechnologies Corporation (ADPT) Q1 2025 Earnings Call TranscriptMay 1, 2025 | seekingalpha.comAdaptive Biotechnologies Corporation 2025 Q1 - Results - Earnings Call PresentationMay 1, 2025 | seekingalpha.comAdaptive Biotechnologies Reports First Quarter 2025 Financial ResultsMay 1, 2025 | globenewswire.com51,694 Shares in Adaptive Biotechnologies Co. (NASDAQ:ADPT) Bought by Dark Forest Capital Management LPDark Forest Capital Management LP acquired a new position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 51,694 shares of the company'May 1, 2025 | marketbeat.comAdaptive Biotechnologies Q1 2025 Earnings PreviewApril 30, 2025 | msn.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Acquired by Voya Investment Management LLCVoya Investment Management LLC lifted its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 6,121.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,428,710 shares of the company's stock after acquApril 30, 2025 | marketbeat.comRenaissance Technologies LLC Buys 60,385 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)Renaissance Technologies LLC boosted its stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 35.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 229,785 shares of the company's stock after acquiriApril 30, 2025 | marketbeat.comLegal & General Group Plc Buys 97,798 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)Legal & General Group Plc boosted its stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 902.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 108,630 shares of the company's stock afteApril 30, 2025 | marketbeat.comAdaptive Biotechnologies (ADPT) Expected to Announce Quarterly Earnings on ThursdayAdaptive Biotechnologies (NASDAQ:ADPT) will be releasing its Q1 2025 earnings after the market closes on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-adaptive-biotechnologies-co-stock/)April 26, 2025 | marketbeat.comJPMorgan Chase & Co. Lowers Stock Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT)JPMorgan Chase & Co. cut its holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 25.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 659,206 shares of the company's stock afterApril 22, 2025 | marketbeat.comFranklin Resources Inc. Invests $443,000 in Adaptive Biotechnologies Co. (NASDAQ:ADPT)Franklin Resources Inc. bought a new position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 73,844 shares of the company's stock, valued at approApril 20, 2025 | marketbeat.comCerity Partners LLC Reduces Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT)Cerity Partners LLC reduced its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 31.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 478,448 shares of the company's stock aftApril 16, 2025 | marketbeat.comPictet Asset Management Holding SA Trims Stock Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT)Pictet Asset Management Holding SA lessened its stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 97.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,937 shares of the company's stock aApril 14, 2025 | marketbeat.comVanguard Group Inc. Has $64.24 Million Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)Vanguard Group Inc. grew its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 0.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 10,714,888 shares of the company's stock after acquiring an additional 75,448 shares during thApril 14, 2025 | marketbeat.comTrexquant Investment LP Takes Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)Trexquant Investment LP acquired a new stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 185,868 shares of the company's stock, valued at approximatelApril 13, 2025 | marketbeat.comExodusPoint Capital Management LP Takes $1.48 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)ExodusPoint Capital Management LP purchased a new stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 246,865 shares of the company's stock, valued at approximatelApril 12, 2025 | marketbeat.comAdaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025April 10, 2025 | globenewswire.comAdaptive Biotechnologies (NASDAQ:ADPT) Trading Up 9.4% - Here's What HappenedAdaptive Biotechnologies (NASDAQ:ADPT) Trading 9.4% Higher - Time to Buy?April 10, 2025 | marketbeat.comAdaptive Biotechnologies receives expanded medical coverage of clonoSEQApril 9, 2025 | markets.businessinsider.comAdaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell LymphomaApril 8, 2025 | globenewswire.comMassachusetts Financial Services Co. MA Boosts Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)Massachusetts Financial Services Co. MA grew its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 17.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,370,919 shares of the comApril 8, 2025 | marketbeat.comCinctive Capital Management LP Buys Shares of 241,316 Adaptive Biotechnologies Co. (NASDAQ:ADPT)Cinctive Capital Management LP purchased a new stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 241,316 shares of the company's stock, valued at apApril 6, 2025 | marketbeat.comPrudential Financial Inc. Acquires 467,751 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)Prudential Financial Inc. increased its holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 3,290.8% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 481,965 shares of the company's stock after buying an additional 467,751 sApril 4, 2025 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Down - Here's What HappenedAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Down - Time to Sell?April 1, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Adaptive Biotechnologies (ADPT) and Alnylam Pharma (ALNY)March 31, 2025 | markets.businessinsider.comSwiss National Bank Takes $1.22 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)Swiss National Bank acquired a new stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 203,100 shares of the company's stock, valued at approximately $1,218,000. Swiss National BankMarch 30, 2025 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Trading Down 8.2% - Here's What HappenedAdaptive Biotechnologies (NASDAQ:ADPT) Stock Price Down 8.2% - What's Next?March 29, 2025 | marketbeat.comInsider Selling: Adaptive Biotechnologies Co. (NASDAQ:ADPT) Insider Sells 1,698 Shares of StockAdaptive Biotechnologies Co. (NASDAQ:ADPT - Get Free Report) insider Harlan S. Robins sold 1,698 shares of the business's stock in a transaction dated Monday, March 24th. The shares were sold at an average price of $9.00, for a total value of $15,282.00. Following the completion of the transaction, the insider now directly owns 1,279,524 shares of the company's stock, valued at approximately $11,515,716. This trade represents a 0.13 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.March 27, 2025 | marketbeat.comAdaptive Biotechnologies Co. (NASDAQ:ADPT) Insider Sells $15,282.00 in StockMarch 27, 2025 | insidertrades.comAdaptive Biotechnologies (NASDAQ:ADPT) Hits New 52-Week High - Here's WhyAdaptive Biotechnologies (NASDAQ:ADPT) Hits New 52-Week High - Here's What HappenedMarch 25, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 39,831 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT)Charles Schwab Investment Management Inc. raised its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 4.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 956,574 shares of the company's stock after acquiring an additional 39March 25, 2025 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up - Here's What HappenedAdaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up - Should You Buy?March 22, 2025 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Raised to "Buy" at The Goldman Sachs GroupThe Goldman Sachs Group upgraded shares of Adaptive Biotechnologies from a "neutral" rating to a "buy" rating and set a $9.00 target price on the stock in a report on Friday.March 22, 2025 | marketbeat.comGoldman Sachs Upgrades Adaptive Biotechnologies (ADPT)March 22, 2025 | msn.comAdaptive Biotechnologies upgraded to Buy from Neutral at Goldman SachsMarch 21, 2025 | markets.businessinsider.comAdaptive Biotechnologies (ADPT) was upgraded to a Buy Rating at Goldman SachsMarch 21, 2025 | markets.businessinsider.comAdaptive Biotech rises as Goldman Sachs upgrades on market dynamicsMarch 21, 2025 | msn.comAdaptive Biotechnologies (ADPT): Among Stocks Insiders Are Selling In MarchMarch 21, 2025 | msn.comAdaptive Biotechnologies (NASDAQ:ADPT) Trading Up 6.9% - Should You Buy?Adaptive Biotechnologies (NASDAQ:ADPT) Trading 6.9% Higher - Still a Buy?March 20, 2025 | marketbeat.comAdaptive Biotechnologies (ADPT) Gets a Buy from BTIGMarch 18, 2025 | markets.businessinsider.comNikko Asset Management Americas Inc. Has $40.93 Million Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT)Nikko Asset Management Americas Inc. lessened its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) by 11.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,833,137 shares of the company's stock afterMarch 18, 2025 | marketbeat.comAdaptive Biotechnologies (NASDAQ:ADPT) Trading Down 6.1% After Insider SellingAdaptive Biotechnologies (NASDAQ:ADPT) Stock Price Down 6.1% Following Insider SellingMarch 14, 2025 | marketbeat.com Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Email Address ADPT Media Mentions By Week ADPT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADPT News Sentiment▼0.980.73▲Average Medical News Sentiment ADPT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADPT Articles This Week▼164▲ADPT Articles Average Week Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Vaxcyte News Today Rhythm Pharmaceuticals News Today PTC Therapeutics News Today Avidity Biosciences News Today Zai Lab News Today Ultragenyx Pharmaceutical News Today Arcellx News Today SpringWorks Therapeutics News Today Akero Therapeutics News Today Organon & Co. News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADPT) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptive Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADPT Stock Free ADPT Stock Alerts